Therapeutic Potential of MicroRNA: A New Target to Treat Intrahepatic Portal Hypertension?

Figure 3

Summary of the miRNAs and the VEGF pathway involved in HSCs. The particular VEGF signaling pathway affected by miRNAs is described in detail in the review.